Related Experiment Video
Updated: Mar 7, 2026
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of
Hasan Rehman1, Ayeesha K Kamal2, Pamela B Morris3
1Houston Methodist Hospital, Houston, TX, USA.
Insights
Mobile health (mHealth) interventions show promise for managing hypertension and hyperlipidemia. While effective for hypertension, more research is needed to confirm mHealth
Area of Science:
- Cardiovascular Disease Research
- Digital Health Technologies
- Public Health Interventions
Background:
- Hypertension and hyperlipidemia are key risk factors for atherosclerotic cardiovascular disease.
- Mobile health (mHealth) utilizes mobile technologies for health objectives, offering cost-effectiveness and engagement.
- mHealth interventions, including text messaging, apps, and wireless devices, are increasingly used in managing these conditions.
Purpose of the Study:
- To review recent studies on the effectiveness of mHealth interventions for hypertension and hyperlipidemia management.
- To assess the current landscape and identify research gaps in mHealth for cardiovascular risk factors.
Main Methods:
- Literature review of recent studies evaluating mHealth interventions.
- Analysis of intervention types, target conditions (hypertension, hyperlipidemia), and reported outcomes.
- Consideration of adaptations for developing countries and reporting guidelines.
Main Results:
- Numerous studies support mHealth for hypertension; few exist for hyperlipidemia.
- Text messaging is common, but mobile apps and wireless devices are emerging.
- mHealth interventions are frequently effective, but comparative efficacy and long-term data are scarce.
- Adaptations for developing countries enhance applicability.
Conclusions:
- mHealth interventions show potential for improving hypertension management.
- Further research is crucial for hyperlipidemia, focusing on high-risk identification and adherence.
- More studies are needed on long-term impacts, comparative effectiveness, and cost-effectiveness of mHealth strategies.
- Adherence to reporting guidelines is recommended for clearer interpretation of mHealth study results.
Purpose Of Review:
Hypertension and hyperlipidemia represent two major risk factors for atherosclerotic cardiovascular disease. Mobile health or mHealth is defined as the use of mobile phone and wireless technologies to support the achievement of health objectives. Management of hypertension, and to some extent hyperlipidemia, has often employed mHealth interventions given lower cost and greater patient engagement compared to traditional methods. These interventions include the use of text messaging, wireless devices, and mobile phone applications. This review considers recent studies evaluating the effectiveness of mHealth interventions in the management of hypertension and hyperlipidemia.
Recent Findings:
Numerous studies have evaluated the role of mHealth interventions in the management of hypertension, while very few have evaluated their role in hyperlipidemia. Text messaging has been used most frequently. However, the trend is shifting towards the use of mobile phone applications and wireless devices. Interventions in developing countries have been modified for greater applicability to local settings. mHealth interventions were found to be frequently effective. However, studies comparing the relative efficacy of various mHealth strategies are scarce. Long-term cardiovascular outcomes data and analyses relating to cost effectiveness are also lacking. mHealth interventions may be effective in improving hypertension management. More studies are needed to evaluate the role of mHealth strategies in hyperlipidemia management, particularly in identifying high-risk individuals and improving medication adherence. Studies assessing the long-term impact of these interventions, comparing different interventions and analyzing their relative cost effectiveness, are also needed. Following recently published guidelines on reporting results of mHealth interventions will provide a more meaningful context for interpreting these promising early studies.
Related Concept Videos
01:23Hypertension V: Nursing Management
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
01:26Atherosclerosis III: Management
01:18Hypertension and Regulation of Blood Pressure
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies